Evidence map›Paper›PMID 32952546›Full record

ReviewNeural plasticity2020

Circuitry and Synaptic Dysfunction in Alzheimer's Disease: A New Tau Hypothesis.

Siddhartha Mondragón-Rodríguez, Humberto Salgado-Burgos, Fernando Peña-Ortega

Open access · goldAbstract readReview
In one paragraph

Review in Neural plasticity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Early-Life Environment Influence on Late-Onset Alzheimer's Disease.Frontiers in cell and developmental biology · 2022
    Review
  12. Review
  13. Review
  14. Article
  15. The Effects of CSF Neurogranin andFrontiers in aging neuroscience · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Siddhartha Mondragón-RodríguezCONACYT National Council for Science and Technology, México, Mexico.ORCID 0000-0003-1335-226X
Humberto Salgado-BurgosUADY Neurosciences Department, Autonomous University of Yucatán, 97000 Mérida, Yucatán, Mexico.
Fernando Peña-OrtegaUNAM Developmental Neurobiology and Neurophysiology, Institute of Neurobiology, National Autonomous University of México, Querétaro, Mexico.
Autonomous University of Yucatán · MXSecretaría de Ciencia, Humanidades, Tecnología e Innovación · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For more than five decades, the field of Alzheimer's disease (AD) has focused on two main hypotheses positing amyloid-beta (A

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsBrainHumansMicrotubulesModels, NeurologicalNeuronal PlasticityNeuronsPhosphorylationSynapsestau ProteinsAmyloid beta-Peptidestau Proteins

Identifiers

PMID32952546
PMCPMC7481966
OpenAlexW3081767050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.